ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BIOG Biotech Growth Trust (the) Plc

995.00
8.00 (0.81%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  8.00 0.81% 995.00 979.00 988.00 998.00 976.00 976.00 87,569 16:29:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt -32.42M -41.3M -1.0034 -9.92 409.53M

The Biotech Growth Trust Plc - Transaction in Own Shares

14/06/2019 5:05pm

PR Newswire (US)


Biotech Growth (LSE:BIOG)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Biotech Growth Charts.

For immediate release

14 June 2019

THE BIOTECH GROWTH TRUST PLC

(the "Company")

MARKET PURCHASE OF COMPANY’S OWN SHARES

Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held 11 July 2018 to make market purchases of the Company’s own shares up to an aggregate maximum of 8,356,271 that a market total of 275,000 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 699.84 pence per share.

Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 48,544,507. The Company does not currently hold any Ordinary shares in treasury.

The figure of 48,544,507 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: 020 3 170 4913

Copyright e 14 PR Newswire

1 Year Biotech Growth Chart

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

1 Month Biotech Growth Chart

Your Recent History

Delayed Upgrade Clock